Johnson and Johson to discontinue late-stage study of RSV vaccine Ruchika Sharma31 March 2023 4:00 PM ISTPfizer and GSK are running a tight race to tap into the RSV vaccine market, which is estimated to be more than $5 billion and could exceed $10 billion...
ICMR nod to RT-qPCR kit KRIVIDA TRIVUS for detection of Influenza, SARS CoV2, Respiratory Syncytial Virus Ruchika Sharma16 March 2023 2:34 PM ISTThe kit has the shortest cycle time of 27 minutes.
Pfizer Respiratory Syncytial Virus Maternal Vaccine candidate gets USFDA priority review Ruchika Sharma24 Feb 2023 1:30 PM ISTRSV is a contagious virus and a common cause of respiratory illness.
Monoclonal antibody treatment improves outcomes of respiratory syncytial virus infection outcomes in infants Jacinthlyn Sylvia20 Feb 2023 10:15 AM ISTWithout a discernible increase in adverse events, nirsevimab, motavizumab, and palivizumab were linked to significant improvements in the prevention...
Moderna gets USFDA Breakthrough Therapy Designation for RSV vaccine Ruchika Sharma1 Feb 2023 4:00 PM ISTmRNA-1345 is an investigational RSV vaccine that consists of a single mRNA sequence encoding for a stabilized prefusion F glycoprotein.
Pfizer secures USFDA priority review for RSV vaccine for older adults Ruchika Sharma8 Dec 2022 3:00 PM ISTRSV is a contagious virus and a common cause of respiratory illness.
Sanofi gets European Commission nod for Beyfortus to prevent RSV disease in infants Ruchika Sharma5 Nov 2022 3:00 PM ISTRSV is the most common cause of LRTI, including bronchiolitis and pneumonia, in infants.
GSK gets USFDA priority review for RSV older adult vaccine Ruchika Sharma4 Nov 2022 12:15 PM ISTGSK’s RSV older adult vaccine candidate contains a recombinant subunit prefusion RSV F glycoprotein antigen (RSVPreF3) combined with GSK’s proprietary...
GSK marketing authorisation application for RSV older adult vaccine accepted by EMA under accelerated assessment Ruchika Sharma31 Oct 2022 3:44 PM ISTRespiratory Syncytial Virus is a common contagious virus affecting the lungs and breathing passages.
GSK RSV vaccine for older adults under Japanese regulator review Ruchika Sharma23 Oct 2022 11:53 AM ISTRSV is a common contagious virus affecting the lungs and breathing passages.
Maternal administration of RSVpreF Vaccine Prevents RSV Infection in Infants: NEJM MD Bureau28 April 2022 9:30 AM ISTRespiratory syncytial virus (RSV), a major cause of illness and death in infants worldwide, could be prevented by vaccination during pregnancy. A...
Pfizer to purchase ReViral for Rs 3984 crore Ruchika Sharma10 April 2022 10:00 AM ISTIf successful, Pfizer believes annual revenue for these programs has the potential to reach or exceed USD 1.5 billion.
